Log in

Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients

  • Original article
  • Published:
Journal of Hepato-Biliary-Pancreatic Sciences

Abstract

Background/purpose

The aim of this study was to evaluate the clinical usefulness of diffusion-weighted magnetic resonance imaging (DWI) in patients with pancreatic cancer by comparing the apparent diffusion coefficient (ADC) value with clinicopathologic features.

Methods

Twenty-two consecutive patients (12 men, 10 women; mean age 64.4 years) with pancreatic cancer underwent DWI before surgery. We retrospectively investigated the correlations between tumor ADC value and clinicopathologic features.

Results

Apparent diffusion coefficient value was significantly lower for pancreatic cancer than for noncancerous tissue (P < 0.001). Receiver operating characteristic analysis yielded an optimal ADC cutoff value of 1.21 × 10−3 mm2/s to distinguish pancreatic cancer from noncancerous tissue. There was a significant negative correlation between ADC value and tumor size (r = −0.59, P = 0.004) and between ADC value and number of metastatic lymph nodes (r = −0.56, P = 0.007). Tumors with low ADC value had a significant tendency to show high portal venous system invasion (P = 0.02) and extrapancreatic nerve plexus invasion (P = 0.01).

Conclusions

Apparent diffusion coefficient value appears to be a promising parameter for detecting pancreatic cancer and evaluating the degree of malignancy of pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Freeny PC, Marks WM, Ryan JA, Traverso LW. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology. 1988;166:125–33.

    CAS  PubMed  Google Scholar 

  2. O’Malley ME, Boland GW, Wood BJ, Fermanz-del Castillo C, Warshaw AL, Mueller PR. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol. 1999;173:1513–8.

    PubMed  Google Scholar 

  3. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Miyayama S, Takashima T, et al. Small pancreatic adenocarcinoma: efficacy of MR imaging with fat suppression and gadolinium enhancement. Radiology. 1994;193:683–8.

    CAS  PubMed  Google Scholar 

  4. Johnson PT, Outwater EK. Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology. 1999;212:213–8.

    CAS  PubMed  Google Scholar 

  5. LeBihan D, Turner R. Intravoxel incoherent motion imaging using spin echos. Magn Reson Med. 1991;19:221–7.

    Article  CAS  Google Scholar 

  6. Lebihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravixel incoherent motions: application to diffusion and perfusion neurogenic disorders. Radiology. 1986;161:401–7.

    CAS  Google Scholar 

  7. Koh DM, Padhani AR. Diffusion-weighted MRI: a new functional clinical technique for tumor imaging. Br J Radiol. 2006;79:633–5.

    Article  PubMed  Google Scholar 

  8. LeBihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol. 1992;159:591–9.

    CAS  Google Scholar 

  9. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging. 1999;24:456–61.

    Article  CAS  PubMed  Google Scholar 

  10. Mürtz P, Flacke S, Träber F, van den Brink JS, Gieseke J, Schild HH. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology. 2002;224:258–64.

    Article  PubMed  Google Scholar 

  11. Yoshikawa T, Kawamitsu H, Mitchell DG, Ohno Y, Ku Y, Seo Y, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol. 2006;187:1521–30.

    Article  PubMed  Google Scholar 

  12. Herneth AM, Guccione S, Bednarski M. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol. 2003;45:208–13.

    Article  PubMed  Google Scholar 

  13. Roth Y, Tichler T, Kostenich G, Ruiz-Cabello J, Maiser SE, Cohen JS, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology. 2004;232:685–92.

    Article  PubMed  Google Scholar 

  14. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360:307–8.

    Article  PubMed  Google Scholar 

  15. Muraoka N, Uematsu H, Kimura H, Imamura Y, Fujiwara Y, Murakami M, et al. Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations. J Magn Reson Imaging. 2008;27:1302–8.

    Article  PubMed  Google Scholar 

  16. Niwa T, Ueno M, Ohkawa S, Yoshida T, Doiuchi T, Ito K, et al. Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy. Br J Radiol. 2009;82:28–34.

    Article  CAS  PubMed  Google Scholar 

  17. International Union Against Cancer (UICC). TNM classification of malignant tumors. 6th ed. New York: Weily-Liss; 2002.

  18. Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K. Diagnosis of pancreatic cancer. HPB (Oxford). 2006;8:337–42.

    Article  Google Scholar 

  19. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.

    Article  PubMed  Google Scholar 

  20. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354:379–86.

    Article  CAS  PubMed  Google Scholar 

  21. Peak AS, Sheller A. Risk factors for develo** gadolinium-induced nephrogenic systemic fibrosis. Ann Pharmacother. 2007;41:1481–5.

    Article  PubMed  Google Scholar 

  22. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161:120–5.

    Article  CAS  PubMed  Google Scholar 

  23. Takai S, Satoi S, Toyokawa H, Yanagimoto H, Sugimoto N, Tsuji K, et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas. 2003;26:243–9.

    Article  CAS  PubMed  Google Scholar 

  24. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, et al. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg. 2010;211:196–204.

    Article  PubMed  Google Scholar 

  25. Nakao A, Harada A, Nonami T, Kaneko T, Takagi H. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas. 1996;12:357–61.

    Article  CAS  PubMed  Google Scholar 

  26. Cai YQ, Guo Y, Cai ZL, Gao YG, An NY, Ma L, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16:172–8.

    Article  PubMed  Google Scholar 

  27. Hatakenaka M, Soeda H, Yabuuchi H, Matsuo Y, Kamitani T, Oda Y, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci. 2008;7:23–9.

    Article  PubMed  Google Scholar 

  28. Korc M. Pancreatic cancer-associated stroma production. Am J Surg. 2007;194:S84–6.

    Article  CAS  PubMed  Google Scholar 

  29. Akisik MF, Aisen AM, Sandrasegaran K, Jennings SG, Lin C, Sherman S, et al. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology. 2009;250:103–9.

    Article  PubMed  Google Scholar 

  30. Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol. 2007;189:799–806.

    Article  PubMed  Google Scholar 

  31. Fattahi R, Balci NC, Perman WH, Hsueh EC, Alkaade S, Havlioqlu N, et al. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging. 2009;29:350–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koichi Hayano.

About this article

Cite this article

Hayano, K., Miura, F., Amano, H. et al. Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients. J Hepatobiliary Pancreat Sci 20, 243–248 (2013). https://doi.org/10.1007/s00534-011-0491-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-011-0491-5

Keywords

Navigation